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Background: Idiopathic pulmonary ﬁbrosis is the most frequent interstitial disease with the worst
prognosis. It is characterized by an uncontrolled ﬁbrosis which is difﬁcult to manage. The pathogenesis of
this disease remains unclear with many theories resulting in multiple target therapies. The relation
between ﬁbrosis and vascular remodeling has been debated in the literature with different results that
may seem contradictory.
Aim: We target to evaluate the connection between ﬁbrosis and vascular remodeling in usual interstitial
pneumonia.
Material and methods: 26 cases of idiopathic pulmonary ﬁbrosis were reviewed by 2 pathologists and the
diagnosis of UIP was retained according to the American Thoracic Society's criteria. Fibrotic changes and
vascular remodeling were evaluated blindly. The ﬁbrotic changes were classiﬁed as severe, intermediate
and mild. Vascular occlusion was graded in 4 grades extending from medial hypertrophy (grade 1) to
plexiform lesions of the vascular wall (grade 4).
Results: We noticed that severe degrees of ﬁbrosis were correlated with severe grades of vascular
obstruction. In fact, our 26 cases were classiﬁed as severe ﬁbrosis in 11 cases with grade IV vascular
lesions in 6 cases, intermediate ﬁbrosis in 12 cases with grade II vascular lesions in 8 cases and mild
ﬁbrosis in 3 cases with grade I vascular lesions in all cases.
Conclusion: Many theories have been reported concerning the UIP's pathogenesis. Recently, many au-
thors reported that the primum movens of these lesions was an epithelial/endothelial injury which
induces uncontrolled ﬁbrosis and microvascular remodeling using different pathways. This puts
emphasis on the necessity of multi-target therapies in order to improve the management of this fatal
disease.
© 2015 Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Idiopathic pulmonary ﬁbrosis (IPF) is the most frequent inter-
stitial disease which is classiﬁed among idiopathic interstitial dis-
eases (IIDs). This entity is a ﬁbrosing disease characterized by the
worse prognosis due to its difﬁcult management. In fact, the only
efﬁcient treatment of this entity is the lung transplantation. Its
better management depends on the knowledge of its complex
pathogenesis. IPF is a clinical denomination and the histological
correlation is usual interstitial pneumonia (UIP) which isbderrahman mami Hospital,
(M. Mlika).
ine, Tunis El Manar, Tunisia.
n open access article under the Ccharacterized by a heterogeneous architecture determined by the
succession of normal and ﬁbrotic areas. Microvascular remodeling
is a common phenomenonwhich is frequently reported in UIP. This
phenomenon in association to other factors, deals with the devel-
opment of a pulmonary hypertension (PH) which is associated with
a poor survival [1,2]. Many authors tried to assess the inter-
connection between parenchymal ﬁbrosis and vascular remodel-
ing. We tried to explore this relationship among 26 cases of UIP
diagnosed in our department of Pathology. We tried to emphasize
on the fact that more effective therapeutics may be discovered if
both phenomenon will be more integrated.2. Materials
26 patients with the diagnosis of IPF/UIP were included in thisC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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cording to the American Thoracic Society/European Respiratory
Society International multidisciplinary consensus classiﬁcation of
the idiopathic interstitial pneumonias (IIP). All slides were
reviewed by 2 pathologists. UIP was deﬁned by alternating areas of
normal parenchyma and injured parenchyma characterized by
alveolar collapse, honeycombing and severe organizing ﬁbrous
airspace wall [3] (Fig. 1). Similarly to the article of Parra and co-
workers, we evaluated the ﬁbrosis using a semiquantitative
manner [4]. Grade I was attributed to minimal ﬁbrotic lesions
deﬁned as alveolar collapse with relatively normal lung paren-
chyma. Grade II lesions were characterized by moderate organizing
ﬁbrosis of the wall with ﬁbroblast foci. Grades III and IV were
deﬁned by severe ﬁbrosis of the wall with honeycombing and foci
of actively proliferating ﬁbroblasts and myoﬁbroblasts (Fig. 2).
In order to grade the vascular remodeling, we also used the
criteria of Parra and colleagues. It was evaluated by a semi-
quantitative analysis for different level of vascular obstruction.
Grade I deﬁned isolated hypertrophy of the arterial media. Grade II
corresponded to proliferative intimal lesions. Total occlusion of the
arterial lumen deﬁned grade III and grade IV was characterized by
plexiform lesions (Fig. 3).3. Results
- Baseline characteristic: Between 2006 and 2010, 32 surgical
biopsies were performed in order to explore ILDs. Among these
cases, 80.6% (26 cases) were classiﬁed as UIP, 19.35% (6 cases)
were classiﬁed as NSIP. We focused on the 26 cases of UIP. Our
study was about 6 women and 20 men with a median age of
56.76 (range 37e75).
- Diagnostic criteria: To retain the diagnosis of UIP, all the items
follow were present in all cases: a heterogenous architecture,
honeycombing cysts, ﬁbroblastic foci. Besides, the diagnosis ofFig. 1. Diagnostic criteria of usual interstitial pneumonia: a/ alternating areas of relatively norma
Fibroblast foci within alveolar wall.UIP was retained only after a correlation with clinical and
radiological ﬁndings.
- Morphological results: The different grades of vascular
obstruction were correlated with parenchymal changes. In fact,
grades III and IV were observed in heavily ﬁbrotic pulmonary
parenchyma. Minimal ﬁbrosis was noted in 3 cases with grade I.
In all cases, vascular remodeling was of grade I. Intermediate
ﬁbrosis was noticed in 12 cases. 2 cases were classiﬁed as grade
I, 8 cases were classiﬁed as grade II and 2 cases were classiﬁed as
grade III. Severe ﬁbrosis was noted in 11 cases. One case was
classiﬁed as grade I, 1 casewas classiﬁed as grade II, 3 cases were
classiﬁed as grade III and 6 cases were classiﬁed as grade IV.4. Discussion
Pulmonary ﬁbrosis is refractory to treatment and induces a high
mortality rate. It represents a heterogeneous group of lung disor-
ders dealing with the progressive and irreversible destruction of
lung architecture and death from respiratory failure [5]. IPF is of
unknown etiology and is characterized by a heavy ﬁbrosis dealing
with a life expectancy of 2e6 years after diagnosis [6]. Many
pathogenic theories have been reported within the last decade.
Initial theories supposed that chronic inﬂammation played a key-
role [7]. Then, many authors supposed that this theory wasn't
convincing based on the ﬁnding that consisted in the presence of
epithelial cell injury and abnormal wound repair in the absence of
preceding inﬂammation [8]. Besides, intrinsic defects in the wound
healing response involving lung epithelial cells and ﬁbroblasts have
supposed to play a major role in the pulmonary ﬁbrosis's patho-
genesis [9]. Finally, based on the multiplicity of the theories, many
authors supposed that the pathogenic events must be more com-
plex [10]. Vascular remodeling is a known phenomenon in IPF
dealing with pulmonary hypertension whose prevalence inl parenchyma and ﬁbrosing areas with alveolar collapse. b/ honeycombing areas. c/
Fig. 2. a/ UIP with minimal ﬁbrosis characterized by alveolar collapse with mild interstitial thickening by ﬁbrosis. c/ UIP with moderate ﬁbrosis characterized by high degree of
inﬂammation activity and moderate mural organizing ﬁbrosis. c/ UIP with severe ﬁbrosis characterized by severe mural organizing ﬁbrosis.
Fig. 3. Distortion of the vascular wall architecture in ﬁbrotic areas. a/ Grade I lesions characterized by isolated hypertrophy of the arterial media. b/ Grade II lesions characterized by
proliferative intimal cells. c/ Grade III lesions characterized by the total occlusion of the arterial lumen by ﬁbrosis tissue. d/ Grade IV lesions characterized by plexiform lesions and
major proliferation of elastic ﬁbres in the internal and external elastic lumina of the vascular wall.
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experimental model, Farkas and colleagues have recently shown
that the intimate interconnection between ﬁbrosis and PH via ef-
fects of growth factors on the pulmonary microcirculation [12].
However, the accurate mechanisms haven't been assessed.
Vascular remodeling phenomenon seems to be the result of
inﬂammatory changes instead of the modiﬁcation of the vascular
ﬂow [4]. Plexiform lesions with abundant atypical endothelial cells
are reported [13]. Regarding their origin, it has been postulated that
these cells are derived from resident vascular smooth muscle cells
and/or from adventitial ﬁbroblasts via de-differentiation of the
former or differentiation of the latter [14]. Numerous growth fac-
tors have been implicated in the development of the pulmonary
vascular system. The most widely investigated is the Vascular
Endothelial Growth Factor (VEGF) which is implicated in angio-
genesis, vasculogenesis and alveologenesis. Epithelial cells are a
predominant source of VEGF during lung development. In adult
ﬁbrotic lung, endothelial apoptosis is induced by injury and
remodeling. This fact results in the decrease of the expression of
VEGF in the damaged lung. This fact illustrates that epithelial injury
results in both ﬁbrosis and vascular remodeling. Besides, trans-
forming growth factor TGF-B is important for coordinated vasculardevelopment.
It is documented that TGF B is a key factor in alveolar branching
and increased TGF B activity is associated with progressive ﬁbrosis
in ILD and endothelial cell apoptosis [12].
Concerning the phenomenon of hypertrophy of the media, the
pathways seem to be more complex. It is possible that the
remodeled pulmonary microvasculature perpetuates the progres-
sion of the underlying ILD and pulmonary ﬁbrosis via mediators
secreted by injured endothelial cells, endothelial to mesenchymal
transition and altered perivascular mesenchyma [15].
Recently, it has been reported that the pathobiology underlying
the vascular remodeling and ﬁbrosis of the parenchyma are closely
intertwined but the results concerning vascular remodeling are
quite discordant. In fact, TurnereWarwick has likely reported that
ﬁbrotic lungs have increased vessel density, on the other hand,
Ebina and colleagues showed contradictory ﬁndings [15e17]. In our
study, we tried to analyze only ﬁbrotic regions and we noticed that
the more severe the ﬁbrosis is, the most important is the vascula-
ture remodeling. These results may seem contradictory but may be
explained by the heterogeneity of UIP and the difference in the
areas focused on by the different authors. Published reports indi-
cate that ﬁbrotic areas have fewer blood vessels. This result was
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highly vascularized [17,18]. In fact, in ﬁbrotic regions, the increase of
angiostatic molecules and the decreased amount of VEGF because
of the injury of the epithelial/endothelial cells is an attempt to
decrease the progressive ﬁbrogenesis [12]. On the other hand, in
areas adjacent to ﬁbrotic lung tissue, it is plausible that the increase
of VEGF amount derived from apoptotic epithelial cells deals with a
high vascular density [19]. The latter phenomenon may explain the
authors of some authors whomay focused on periﬁbrotic areas and
who reported increased vascular remodeling with severe ﬁbrosis.
According to our results, pulmonary ﬁbrosis and vascular remod-
eling result from the same primummovens which is the epithelial/
endothelial cell injury of unknown origin, resulting in the activa-
tion of myoﬁbroblasts in one side and the decrease of secretion of
VEGF from apoptotic cells in ﬁbrotic regions in the other side. The
former phenomenon results in an uncontrolled ﬁbrosis in predis-
posed persons and the latter results in the rarefaction of the vessels
in ﬁbrotic regions. The best knowledge of the pathogenesis of the
IPF plays a key role in order to improve the management of this
entity. In fact, till now, the lung transplant remains the only effec-
tive therapeutic modality in cases resistant to medical drugs [10].
Our results highlight the correlation between ﬁbrosis and vascular
remodeling and put emphasis on the necessity of multiple target
therapies in order to control the ﬁbrosis such as metalloproteases,
micro RNA miR-21, epigenetic changes in ﬁbroblasts but also vas-
culogenesis by targeting the most relevant vascular enhancers such
as VEGF [10,20,21].
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